Photo of Timothy (Tim) Edwin Wilens, MD

Timothy (Tim) Edwin Wilens, MD

  • Chief, Division of Child and Adolescent Psychiatry
  • Co-Director, Center for Addiction Medicine
  • Director, Substance Abuse Services in Pediatric Psychopharmacology


Accepting New Patients




Centers & Specialties

MassGeneral Hospital for Children

Clinical Interests
  • Psychopharmacology (Adult)
  • Psychopharmacology (pediatric)
  • Attention deficit hyperactivity disorder (ADHD)
Medical Education
  • MD, University of Michigan Medical School
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital
Board Certifications
  • Psychiatry
  • Addiction Psychiatry
  • Child & Adolescent Psychiatry
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Great-West Healthcare (formally One Health Plan)
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Medicare - ACD
  • OSW - Maine
  • OSW - New Hampshire
  • Private Health Care Systems (PHCS)
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Behavioral Health
  • United Behavioral Health - MGH
Patient Age Group
Pediatric and Adult

Edit Profile


Dr. Timothy Wilens is Associate Professor of Psychiatry at Harvard Medical School in Boston, Massachusetts. In addition, he is Director of Substance Abuse Services in the Clinical and Research Program in Pediatric Psychopharmacology at Massachusetts General Hospital. Dr. Wilens earned his BS in literature, science, and arts at the University of Michigan Honors College and his MD at the University of Michigan Medical School in Ann Arbor. His residency in child, adolescent, adult, and addiction psychiatry was completed at Massachusetts General Hospital under the auspices of Harvard Medical School in Boston.

Dr. Wilens' research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance abuse, and the pharmacotherapy of ADHD and juvenile bipolar disorder across the lifespan. His peer-reviewed articles concerning these and related topics number more than 200, and are published in prestigious journals such as the American Journal of Psychiatry, Archives of General Psychiatry, and Pediatrics. Dr. Wilens has also published more than 60 book chapters, and 300 abstracts and presentations for national and international scientific meetings.

Dr. Wilens is a Distinguished Fellow of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry, serves as a scientific reviewer for 22 journals, and is active in a number of other local and national professional societies. Dr. Wilens is named consistently among "The Best of Boston" in Child/Adult Psychiatry and "The Best Doctors in America."

Edit Profile

Research & Publications


View my most recent publications at PubMed

Edit Profile

News & Events

  • College students who misuse stimulants more likely to have ADHD, substance-use disorder

    A new study by Massachusetts General Hospital investigators finds that college students who misuse stimulant drugs are more likely to have attention-deficit hyperactivity disorder, conduct disorder or substance-use disorder than are students not misusing stimulants.

  • Wilens Honored with Endowed Chair in Addiction Medicine

    Timothy E. Wilens, MD, chief of the Division of Child and Adolescent Psychiatry at MassGeneral Hospital for Children (MGHfC), was honored as the inaugural incumbent of the MGH Trustees Endowed Chair in Addiction Medicine.

  • Wilens named chief of Child and Adolescent Psychiatry

    The MGH Department of Psychiatry recently announced that Timothy E. Wilens, MD, has been named the new chief of the Division of Child and Adolescent Psychiatry, effective Aug. 1.

  • The truth about Molly

    Dr. Timothy Wilens, director of the Center for Addiction Medicine and Substance Abuse Services in Pediatric Psychopharmacology at MassGeneral for Children, discusses Molly, the new club drug that's been associated with overdoses in New England.

  • ADHD and Substance Abuse in Children, Adolescents

    The results of two long-term studies conducted by Massachusetts General Hospital researchers have shown that attention-deficit hyperactivity disorder (ADHD) significantly increases the risk of cigarette smoking and substance abuse in both boys and girls.

  • Long-term study data supports association between childhood ADHD and substance abuse risk

    An analysis of more than 10 years of data confirms that ADHD alone significantly increases the risk of future cigarette smoking and substance abuse in both boys and girls.

  • Managing Your Kid's Behavioral Health

    In the morning, participants will learn about attention deficit hyperactivity disorder (ADHD), obsessive compulsive disorder (OCD) and severe moodiness. The afternoon will feature presentations on disruptive disorders and co-occurring medical problems in children. The afternoon will also include presentations by parents and a series of interactive talks on parenting children with anxiety, eating disorders and personality disorders.


Child & Adolescent Psychiatry
55 Fruit Street
Boston MA, 02114-2696
Phone 1: 617-724-5600
Fax: 617-724-3742

Edit Profile

Back to Top